$60,000 of TEMPUS AI INC. lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Healthcare AI"
You can find more data on corporate lobbying on Quiver Quantitative.
TEM Insider Trading Activity
TEM insiders have traded $TEM stock on the open market 227 times in the past 6 months. Of those trades, 0 have been purchases and 227 have been sales.
Here’s a breakdown of recent trading of $TEM stock by insiders over the last 6 months:
- ERIC P LEFKOFSKY (CEO and Chairman) has made 0 purchases and 82 sales selling 6,652,594 shares for an estimated $389,891,658.
- BRADLEY A KEYWELL has made 0 purchases and 4 sales selling 775,364 shares for an estimated $27,083,934.
- ERIK PHELPS (EVP & Chief Admin & Legal Off) has made 0 purchases and 20 sales selling 128,151 shares for an estimated $9,802,522.
- ANDREW POLOVIN (EVP and General Counsel) has made 0 purchases and 27 sales selling 112,835 shares for an estimated $8,249,522.
- RYAN FUKUSHIMA (Chief Operating Officer) has made 0 purchases and 23 sales selling 110,802 shares for an estimated $6,616,383.
- JAMES WILLIAM ROGERS (Chief Financial Officer) has made 0 purchases and 23 sales selling 88,183 shares for an estimated $5,852,572.
- SCOTT GOTTLIEB has made 0 purchases and 9 sales selling 55,675 shares for an estimated $2,674,142.
- RYAN M BARTOLUCCI (Chief Accounting Officer) has made 0 purchases and 10 sales selling 32,580 shares for an estimated $2,186,740.
- JENNIFER A DOUDNA has made 0 purchases and 8 sales selling 11,811 shares for an estimated $642,886.
- WAYNE A.I. FREDERICK has made 0 purchases and 6 sales selling 12,000 shares for an estimated $576,278.
- NADJA WEST has made 0 purchases and 10 sales selling 8,443 shares for an estimated $414,309.
- DAVID R EPSTEIN has made 0 purchases and 4 sales selling 1,980 shares for an estimated $99,681.
- THEODORE LEONSIS sold 770 shares for an estimated $51,020
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TEM Analyst Ratings
Wall Street analysts have issued reports on $TEM in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 06/30/2025
- Morgan Stanley issued a "Overweight" rating on 05/09/2025
- Needham issued a "Buy" rating on 05/07/2025
- BTIG issued a "Buy" rating on 04/21/2025
- TD Cowen issued a "Buy" rating on 02/05/2025
To track analyst ratings and price targets for TEM, check out Quiver Quantitative's $TEM forecast page.
TEM Price Targets
Multiple analysts have issued price targets for $TEM recently. We have seen 8 analysts offer price targets for $TEM in the last 6 months, with a median target of $70.0.
Here are some recent targets:
- Subbu Nambi from Guggenheim set a target price of $75.0 on 06/30/2025
- Michael Ryskin from B of A Securities set a target price of $70.0 on 06/25/2025
- David Westenberg from Piper Sandler set a target price of $70.0 on 05/15/2025
- Tejas Savant from Morgan Stanley set a target price of $65.0 on 05/09/2025
- Ryan MacDonald from Needham set a target price of $70.0 on 05/07/2025
- Mark Massaro from BTIG set a target price of $60.0 on 04/21/2025
- Rachel Vatnsdal from JP Morgan set a target price of $55.0 on 02/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
